COLGATE PALMOLIVE CO Earnings Summary — Q1 2026
Colgate-Palmolive Delivers Strong 8.4% Revenue Growth in Q1 2026 Despite Net Profit Pressure
Key Takeaways
- Revenue reached a multi-quarter high of $5.32 billion, representing 8.41% year-over-year growth.
- Net income attributable to common shareholders was $646 million, down from $690 million in the prior year quarter.
- Operating income recovered significantly to $964 million from a depressed $92 million in Q4 2025.
- Selling, General & Administrative expenses rose to $2.08 billion, indicating continued investment in brand support.
- The company continues to reduce its shares outstanding, down 1.21% year-over-year to 802 million basic shares.
- Gross profit margins remain robust at 60.6%, benefiting from strong pricing power in core categories.
- Hill's Pet Nutrition and premium oral care remain key strategic growth diversifiers for the portfolio.
Management Guidance
Management remains focused on productivity programs and digital transformation to protect margins against inflationary pressures and currency headwinds.
Sentiment Shift
Stable
While revenue growth is accelerating, net profit has seen a year-over-year decline due to higher operating and non-operating expenses.
Outlook
The company is positioned as a high-quality compounder with dominant market share in oral care (~40%) and strong cash flow generation, despite a thin equity base from aggressive capital returns.
From the Annual Report (Key Quotes)
“The ability to push through price increases in core categories without sacrificing significant volume speaks to strong brand equity.”
“Strategic shift toward 'Hill's Pet Nutrition' and premium oral care products has successfully diversified the growth profile.”
“The core business remains a cash generative engine with a highly resilient competitive position.”
Official Quarterly Documents
This summary is AI-generated from COLGATE PALMOLIVE CO's latest quarterly filing and earnings call. For informational purposes only — not investment advice.